MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617090123 A) filed by Radionetics Oncology, Inc. on July 24, 2026, for Neuropeptide Y1 Receptor (npy1r) Targeted Therapeutics And Uses Thereof.
Inventors include Xiong, Yifeng; Liu, Junjie; and Zhu, Yunfei.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Described herein are radiotherapeutics that target tumor cells expressing the neuropeptide Y1 receptor (NPY1R) and their use in the treatment and/or diagnosis of cancer.
Disclaimer: Curated by HT Syndication....